Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepNet Acute HCV IV (Ledipasvir/Sofosbuvir in Acute Genotype 1 HCV)
DRKS00006863Phase 2Completed
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ledipasvir in hepatitis C virus infection, sponsored by Medizinische Hochschule Hannover. Started Oct 2014; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on DRKS00006863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00006863.